Dabur Pharma to be Fresenius Kabi Oncology

New Delhi, Jan 5: Dabur Pharma, Ghaziabad based company for cancer research and anticancer products, has received a nod from requisite shareholders for a change in name to Fresenius Kabi Oncology on Monday, Jan 4.

Last year, Fresenius Kabi, subsidiary of a German pharmaceutical company had acquired 73.27 per cent stake in Dabur Pharma from its promoters and certain other shareholders, after which Fresenius Kabi made an open offer for an additional 20 per cent stake in the firm.

OneIndia News (With inputs from Agencies)